These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 3239138)

  • 1. [Antipsoriatic effect of (tape) occlusion].
    Wollina U
    Z Hautkr; 1988 Nov; 63(11):935-9. PubMed ID: 3239138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psoriasis vulgaris--unchanged endothelial reactivity with histochemical markers].
    Wollina U; Hipler C; Knopf B; Koch HJ
    Z Hautkr; 1989 Oct; 64(10):925-7. PubMed ID: 2686249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Occlusive therapy of psoriasis--comparison of clinical effectiveness of short-term and prolonged use].
    Wollina U; Knopf B; Fünfstück V; Geyer A; Hempel E; Simon D
    Z Hautkr; 1990 Aug; 65(8):737-9. PubMed ID: 2126652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basis of occlusive therapy in psoriasis: correcting defects in permeability barrier and calcium gradient.
    Hwang SM; Ahn SK; Menon GK; Choi EH; Lee SH
    Int J Dermatol; 2001 Mar; 40(3):223-31. PubMed ID: 11422532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearing of psoriatic lesions after the application of tape.
    Shore RN
    N Engl J Med; 1985 Jan; 312(4):246. PubMed ID: 3965955
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of psoriasis vulgaris with a hydrocolloid occlusive dressing.
    Friedman SJ
    Arch Dermatol; 1987 Aug; 123(8):1046-52. PubMed ID: 3631982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of plastic occlusive dressings on psoriatic epidermis.
    Fry L; Almeyda J; McMinn RM
    Br J Dermatol; 1970 May; 82(5):458-62. PubMed ID: 5431551
    [No Abstract]   [Full Text] [Related]  

  • 8. The immunohistochemical effect of a hydrocolloid occlusive dressing (DuoDERM E) in psoriasis vulgaris.
    van Vlijmen-Willems IM; Chang A; Boezeman JB; van de Kerkhof PC
    Dermatology; 1993; 187(4):257-62. PubMed ID: 7506086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin.
    Johansen C; Kragballe K; Westergaard M; Henningsen J; Kristiansen K; Iversen L
    Br J Dermatol; 2005 Jan; 152(1):37-42. PubMed ID: 15656798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lectin binding of psoriatic skin].
    Wollina U; Hipler C; Henkel U; Schaarschmidt H; Knopf B
    Z Hautkr; 1986 Sep; 61(17):1241-9. PubMed ID: 3776279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis.
    Nagpal S; Thacher SM; Patel S; Friant S; Malhotra M; Shafer J; Krasinski G; Asano AT; Teng M; Duvic M; Chandraratna RA
    Cell Growth Differ; 1996 Dec; 7(12):1783-91. PubMed ID: 8959347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of short-term occlusion on the cutaneous flora in atopic dermatitis and psoriasis.
    Rajka G; Aly R; Bayles C; Tang Y; Maibach H
    Acta Derm Venereol; 1981; 61(2):150-3. PubMed ID: 6165193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
    Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
    J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidermal lectin binding in psoriasis vulgaris. III. Galactosamine and glucosamine glycoconjugates].
    Wollina U; Knopf B; Hipler C; Henkel U; Fünfstück V
    Dermatol Monatsschr; 1988; 174(10):613-7. PubMed ID: 3197898
    [No Abstract]   [Full Text] [Related]  

  • 15. A new formulation of an occlusive dressing containing betamethasone valerate 0.1% in the treatment of mild to moderate psoriasis.
    Pacifico A; Daidone R; Peris K
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):153-7. PubMed ID: 16441622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of topically applied indigo naturalis ointment in patients with plaque-type psoriasis.
    Lin YK; Wong WR; Chang YC; Chang CJ; Tsay PK; Chang SC; Pang JH
    Dermatology; 2007; 214(2):155-61. PubMed ID: 17341866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of interleukin-4 receptors on psoriatic epidermal cells.
    Prens E; Hegmans J; Lien RC; Debets R; Troost R; van Joost T; Benner R
    Am J Pathol; 1996 May; 148(5):1493-502. PubMed ID: 8623919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidermal lectin binding in psoriasis vulgaris. I. Galactosyl glycoconjugates].
    Wollina U; Knopf B; Hipler C; Henkel U; Fünfstück V; Schlesier F
    Dermatol Monatsschr; 1988; 174(4):193-6. PubMed ID: 3042480
    [No Abstract]   [Full Text] [Related]  

  • 19. A new therapeutic approach to treat psoriasis by inhibition of fatty acid oxidation by Etomoxir.
    Caspary F; Elliott G; Navé BT; Verzaal P; Rohrbach M; Das PK; Nagelkerken L; Nieland JD
    Br J Dermatol; 2005 Nov; 153(5):937-44. PubMed ID: 16225603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an in vitro psoriatic skin model by tissue engineering.
    Jean J; Lapointe M; Soucy J; Pouliot R
    J Dermatol Sci; 2009 Jan; 53(1):19-25. PubMed ID: 18783923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.